Infarct scar: A dynamic tissue

Cardiovascular Research

Volumn 46, Issue 2, 2000, Pages 250-256

  Sun, Yao ^a   Weber, Karl T ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Angiotensin; Fibrosis; Growth factors; Infarction

Indexed keywords

ALPHA ACTIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANGIOGENESIS; EXTRACELLULAR MATRIX; HEART INFARCTION; HEART MUSCLE FIBROSIS; HUMAN; HUMAN TISSUE; MORPHOLOGY; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; REVIEW; SCAR FORMATION; TISSUE REPAIR;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CICATRIX; COLLAGEN; EXTRACELLULAR MATRIX; FIBROBLASTS; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIUM; NECROSIS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, ANGIOTENSIN; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 0034074371     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(00)00032-8     Document Type: Review

References (58)

1. Jugdutt B.I., Amy R.W.M. Healing after myocardial infarction in the dog: changes in infarct hydroxyproline and topography. J Am Coll Cardiol. 7:1986;91-102.
2. Jugdutt B.I., Schwarz-Michorowski B.L., Khan M.I. Effect of long-term captopril therapy on left ventricular remodeling and function during healing of canine myocardial infarction. J Am Coll Cardiol. 19:1992;713-721.
3. Gabbiani G., Hirschel B.J., Ryan G.B., Statkov P.R., Majno G. Granulation tissue as a contractile organ. A study of structure and function. J Exp Med. 67:1972;719-734.
4. Darby I., Skalli O., Gabbiani G. α-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest. 63:1990;21-29.
5. Lipper S., Kahn L.B., Reddick R.L. The myofibroblast. Pathol Annu. 15:1980;409-441.
6. Birkedal-Hansen H., Moore W.G.I., Bodden M.K., et al. Matrix metalloproteinases: A review. J Cell Biochem. 51:1993;326-335.
7. Cleutjens J.P.M., Kandala J.C., Guarda E., Guntaka R.V., Weber K.T. Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol. 27:1995;1281-1292.
8. Sun Y, Zhang JQ, Zhang J, Lamparter S. Cardiac remodeling by fibrous tissue following infarction in rats. J Lab Clin Med 2000 (in press).
9. Cleutjens J.P.M., Verluyten M.J.A., Smits J.F.M., Daemen M.J.A.P. Collagen remodeling after myocardial infarction in the rat heart. Am J Pathol. 147:1995;325-338.
10. Sun Y., Cleutjens J.P.M., Diaz-Arias A.A., Weber K.T. Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat. Cardiovasc Res. 28:1994;1423-1432.
11. Whittaker P. Unravelling the mysteries of collagen and cicatrix after myocardial infarction. Cardiovasc Res. 31:1996;19-27.
12. Volders P.G.A., Willems I.E.M.G., Cleutjens J.P.M., Arends J.-W., Havenith M.G., Daemen M.J.A.P. Interstitial collagen is increased in the non-infarcted human myocardium after myocardial infarction. J Mol Cell Cardiol. 25:1993;1317-1323.
13. Van Krimpen C., Smits J.F.M., Cleutjens J.P.M., et al. DNA synthesis in the non-infarcted cardiac interstitium after left coronary artery ligation in the rat heart: effects of captopril. J Mol Cell Cardiol. 23:1991;1245-1253.
14. Litwin S.E., Litwin G.M., Raya T.E., Warner A.L., Goldman S. Contractility and stiffness of noninfarcted myocardium after coronary ligation in rats: effects of chronic angiotensin converting enzyme inhibition. Circulation. 83:1991;1028-1037.
15. Pelouch V., Dixon I.M.C., Sethi R., Dhalla N.S. Alteration of lagenous protein profile in congestive heart failure second myocardial infarction. Mol Cell Biochem. 129:1993;121-131.
16. Sun Y., Weber K.T. Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart. J Mol Cell Cardiol. 28:1996;851-858.
17. Vracko R., Thorning D. Contractile cells in rat myocardial tissue. Lab Invest. 65:1991;214-227.
18. Sappino A.P., Schurch W., Gabbiani G. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest. 63:1990;144-161.
19. Skalli O., Schurch W., Seemayer T., et al. Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins. Lab Invest. 60:1989;275-285.
20. Desmouliere A., Geinoz A., Gabbiani F., Gabbiani G. Transform growth factor-β1 induces α-smooth muscle actin expression granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol. 122:1993;103-111.
21. Willems I.E.M.G., Havenith M.G., De Mey J.G.R., Daemen M.J.A.P. The α-smooth muscle actin-positive cells in healing human myocardial scars. Am J Pathol. 145:1994;868-875.
22. Sun Y., Zhang J.Q., Zhang J., Ramires F.J.A. Angiotensin II transforming growth factor-β1 and repair in the infarcted heart. J Mol Cell Cardiol. 30:1998;1559-1569.
23. Desmouliere A., Redard M., Darby I., Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol. 146:1995;56-66.
24. Zhang G., Moorhead P.J., El Nahas A.M. Myofibroblasts and the progression of experimental glomerulonephritis. Exp Nephrol. 3:1995;308-318.
25. Goumenos D.S., Brown C.B., Shortland J., El Nahas A.M. Myofibroblasts, predictors of progression of mesangial IgA nephropathy. Nephrol Dial Transplant. 9:1994;1418-1425.
26. Johnston C.I. Biochemistry and pharmacology of the renin-angiotensin system. Drugs. 39:1990;21-31.
27. Dzau V.J. Vascular renin-angiotensin system and vascular protection. J Cardiovasc Pharmacol. 22:1993;S1-S9.
28. Campbell D.J., Habener J.F. Cellular localization of angiotensinogen gene expression in brown adipose tissue and mesentery: Quantification of messenger ribonucleic acid abundance using hybridization in situ. Endocrinology. 121:1987;1616-1626.
29. Cassis L.A., Lynch K.R., Peach M.J.J. Localization of angiotensinogen messenger RNA in rat aorta. Circ Res. 62:1988;1259-1262.
30. Lindpaintner K., Lu W., Niedermajer J. Selective activation of cardiac angiotensinogen gene expression in post-infarction ventricular remodeling in the rat. J Mol Cell Cardiol. 25:1993;133-143.
31. Passier R.C.J.J., Smits J.F.M., Verluyten M.J.A., Daemen M.J.A.P. Expression and localization renin and angiotensinogen in rat heart after myocardial infarction. Am J Physiol. 271:1996;H1040-H1048.
32. Hirsch A.T., Opsahl J.A., Lunzer M.M., Katz S.A. Active renin and angiotensinogen in cardiac interstitial fluid after myocardial infarction. Am J Physiol. 276:1999;H1818-1826.
33. Katwa L.C., Tyagi S.C., Campbell S.E., Lee S.J., Cicila G.T., Weber K.T. Valvular interstitial cells express angiotensinogen, cathepsin D and generate angiotensin peptides. Int J Biochem Cell Biol. 28:1996;807-821.
34. Katwa L.C., Campbell S.E., Tyagi S.C., Lee S.J., Cicila G.T., Weber K.T. Cultured myofibroblasts generate angiotensin peptides de novo. J Mol Cell Cardiol. 29:1997;1375-1386.
35. Dzau V.J. Cardiac renin-angiotensin system. Am J Med. 84:1988;22-27.
36. Hirsch A.T., Talsness C.E., Schunkert H., Paul M., Dzau V.J. Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res. 69:1991;475-482.
37. Yamada H., Mendelsohn F.A.O. Localization of angiotensin converting enzyme in rat heart. Circ Res. 68:1991;141-149.
38. Hokimoto S., Yasure R., Yasue H., Fujimoto K., Sakata R., Miyamoto E. Increased angiotensin converting enzyme activity in left ventricular aneurysm of patients after myocardial infarction. Cardiovasc Res. 29:1995;664-669.
39. Yamagishi H., Kim S., Nishikimi T., Takeuchi K., Takeda T. Contribution of cardiac renin-angiotensin system to ventricular remodeling in myocardial-infarcted rats. J Mol Cell Cardiol. 25:1993;1369-1380.
40. Hodsman G.P., Kohauki M., Howes L.G., Johnston C.I. Neurohumoral responses to chronic myocardial infarction in rats. Circulation. 78:1988;376-381.
41. Allen A.M., Yamada H., Mendelsohn F.A.O. In vitro autoradiographic localization of binding to angiotensin receptors in the rat heart. Int J Cardiol. 28:1990;25-33.
42. Sun Y., Weber K.T. Angiotensin II receptor binding following myocardial infarction in the rat. Cardiovasc Res. 28:1994;1623-1628.
43. Sun Y., Weber K.T. Cells expressing angiotensin II receptors in fibrous tissue of rat heart. Cardiovasc Res. 31:1996;518-525.
44. Campbell S.E., Katwa L.C. Angiotensin II stimulated expression of transforming growth factor-β1 in cardiac fibroblasts and myofibroblasts. J Mol Cell Cardiol. 29:1997;1947-1958.
45. Pimentel J.L. Jr., Sundell C.L., Wang S., Kopp J.B., Montero A., Martinez-Maldonado M. Role of angiotensin II in the expression and regulation of transforming growth factor-β in obstructive nephropathy. Kidney Int. 48:1995;1233-1246.
46. Funck R.C., Wilke A., Rupp H., Brilla C.G. Regulation and role of myocardial collagen matrix remodeling in hypertensive heart disease. Adv Exp Med Biol. 432:1997;35-44.
47. Chua C.C., Hamdy R.C., Chua B.H.L. Angiotensin II induces TIMP-1 production in rat heart endothelial cells. Biochim Biophys Acta. 1311:1996;175-180.
48. Cleutjens J.P.M., Blankesteijn W.M., Daemen M.J.A.P., Smits J.F.M. The infarcted myocardium: simply dead tissue, or a lively target for therapeutic interventions. Cardiovasc Res. 44:1999;232-241.
49. Unger T., Culman J., Gohlke P. Angiotensin II receptor blockade and end-organ protection: pharmacological rationale and evidence. J Hypertens Suppl. 16:1998;S3-S9.
50. Tsutsumi Y., Matsubara H., Ohkubo N., et al. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression. Circ Res. 83:1998;1035-1046.
51. Sun Y., Weber K.T. Angiotensin converting enzyme and wound healing in diverse tissues of the rat. J Lab Clin Med. 127:1996;94-101.
52. O'Kane S., Ferguson M.W. Transforming growth factor-βs and wound healing. Int J Biochem Cell Biol. 29:1997;63-78.
53. Smits J.F.M., van Krimpen C., Schoemaker R.G., Cleutjens J.P.M., Daemen M.J.A.P. Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content. J Cardiovasc Pharmacol. 20:1992;772-778.
54. Michel J.B., Lattion A.L., Salzmann J.L., et al. Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ Res. 62:1988;641-651.
55. De Carvalho Frimm C., Sun Y., Weber K.T. Angiotensin II receptor blockade and myocardial fibrosis of the infarcted rat heart. J Lab Clin Med. 129:1997;439-446.
56. Jugdutt B.I., Khan M.I., Judutt S.J., Blinston G.E. Effect of enalapril on ventricular remodeling and function during healing after anterior myocardial infarction in the dog. Circulation. 91:1995;802-812.
57. Schieffer B., Wirger A., Meybrunn M., et al. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type I receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation. 88:1994;2273-2282.
58. De Mey J.G.R., Fazzi G.E. A smooth muscle-like component in rat myocardial infarcts [abstract]. Hypertension. 28:1996;696.